Our Blog
Insights on regulatory affairs, quality, pharmacovigilance and RNA technologies from the Molgenium team.
CMC & Product Development
Analytics Over Trials: The New Biosimilar Pathway and What It Means for CMC
By Dr. Mohamad Toutounji
Sep 22, 2026